Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trial. (2017)

First Author: Snowdon VK
Attributed to:  Transforming Translational Research at the University of Bristol funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pmed.1002248

PubMed Identifier: 28245243

Publication URI: http://europepmc.org/abstract/MED/28245243

Type: Journal Article/Review

Volume: 14

Parent Publication: PLoS medicine

Issue: 2

ISSN: 1549-1277